New approaches to design HIV-1 T-cell vaccines
نویسندگان
چکیده
منابع مشابه
Vaccines. New approaches to immunological problems.
Preparing the books to read every day is enjoyable for many people. However, there are still many people who also don't like reading. This is a problem. But, when you can support others to start reading, it will be better. One of the books that can be recommended for new readers is vaccines new approaches to immunological problems. This book is not kind of difficult book to read. It can be read...
متن کاملApproaches to the design of effective HIV-1 protease inhibitors.
Recently, western countries have recorded a decrease in the death rate imputed to AIDS. This success has been largely attributed to the presence on the market of chemotherapies that inhibit the infectivity of the predominant causative agent, the HIV-1 virus, by targeting essential viral enzymes. One of these is the protease (HIV-1 PR) whose activity is a prerequisite for viral replication. Two ...
متن کاملNew approaches to HIV prevention.
Just as the 1996 International AIDS Conference in Vancouver ushered in the era of effective combination antiretroviral therapy and the 2000 meeting in Durban focused on the HIV/AIDS epidemic in the developing world, the 2006 conference (held August 13-18 in Toronto) may be remembered as the one that brought HIV prevention to the fore. Political considerations aside, it has become abundantly cle...
متن کاملHIV T cell vaccines, the importance of clades.
Development of an HIV vaccine presents a formidable challenge. One of the unresolved, yet central issues is the importance of HIV variability. Here we argue that even with the recent focus on the induction of T cell-mediated immunity, HIV vaccines should match the local circulating HIV clades. Whether used alone or in a combination with vaccines eliciting HIV-neutralizing antibodies, efforts mu...
متن کاملHIV-1 Tat vaccines.
The inexorable spreading of the HIV pandemic and the increasing deaths for AIDS in the developing countries underscore the urgency for an effective, safe and inexpensive vaccine against AIDS. Although many attempts have been made, a candidate vaccine of proven efficacy and safety in non-human primate models is not yet available. This is mostly due to HIV envelope (Env) variability and to the di...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Opinion in HIV and AIDS
سال: 2010
ISSN: 1746-630X
DOI: 10.1097/coh.0b013e32833d2cc0